vs
Assertio Holdings, Inc.（ASRT）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL HEALTH REALTY INCOME TRUST的季度营收约是Assertio Holdings, Inc.的1.8倍（$24.5M vs $13.5M），UNIVERSAL HEALTH REALTY INCOME TRUST同比增速更快（-0.7% vs -57.9%），过去两年UNIVERSAL HEALTH REALTY INCOME TRUST的营收复合增速更高（-1.3% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
ASRT vs UHT — 直观对比
营收规模更大
UHT
是对方的1.8倍
$13.5M
营收增速更快
UHT
高出57.2%
-57.9%
两年增速更快
UHT
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $24.5M |
| 净利润 | — | $4.3M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 34.7% |
| 净利率 | — | 17.7% |
| 营收同比 | -57.9% | -0.7% |
| 净利润同比 | — | -7.2% |
| 每股收益（稀释后） | $-4.54 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTUHT
| Q4 25 | $13.5M | $24.5M | ||
| Q3 25 | $49.5M | $25.3M | ||
| Q2 25 | $29.2M | $24.9M | ||
| Q1 25 | $26.5M | $24.5M | ||
| Q4 24 | $32.2M | $24.6M | ||
| Q3 24 | $29.2M | $24.5M | ||
| Q2 24 | $31.1M | $24.7M | ||
| Q1 24 | $32.4M | $25.1M |
净利润ASRTUHT
| Q4 25 | — | $4.3M | ||
| Q3 25 | $11.4M | $4.0M | ||
| Q2 25 | $-16.4M | $4.5M | ||
| Q1 25 | $-13.5M | $4.8M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | $-2.9M | $4.0M | ||
| Q2 24 | $-3.7M | $5.3M | ||
| Q1 24 | $-4.5M | $5.3M |
营业利润率ASRTUHT
| Q4 25 | -86.7% | 34.7% | ||
| Q3 25 | 23.2% | 33.2% | ||
| Q2 25 | -27.5% | 35.6% | ||
| Q1 25 | -50.0% | 36.8% | ||
| Q4 24 | -41.9% | 37.6% | ||
| Q3 24 | -10.4% | 34.7% | ||
| Q2 24 | -11.6% | 38.7% | ||
| Q1 24 | -13.4% | 37.6% |
净利率ASRTUHT
| Q4 25 | — | 17.7% | ||
| Q3 25 | 23.1% | 15.9% | ||
| Q2 25 | -56.0% | 18.1% | ||
| Q1 25 | -51.1% | 19.5% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | -10.0% | 16.3% | ||
| Q2 24 | -11.8% | 21.3% | ||
| Q1 24 | -13.9% | 21.1% |
每股收益（稀释后）ASRTUHT
| Q4 25 | $-4.54 | $0.32 | ||
| Q3 25 | $0.11 | $0.29 | ||
| Q2 25 | $-0.17 | $0.32 | ||
| Q1 25 | $-0.14 | $0.34 | ||
| Q4 24 | $-3.28 | $0.34 | ||
| Q3 24 | $-0.03 | $0.29 | ||
| Q2 24 | $-0.04 | $0.38 | ||
| Q1 24 | $-0.05 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | $94.0M | $152.4M |
| 总资产 | $267.0M | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资ASRTUHT
| Q4 25 | $63.4M | $6.7M | ||
| Q3 25 | $93.4M | $6.9M | ||
| Q2 25 | $98.2M | $6.6M | ||
| Q1 25 | $87.3M | $7.0M | ||
| Q4 24 | $100.1M | $7.1M | ||
| Q3 24 | $88.6M | $6.4M | ||
| Q2 24 | $88.4M | $5.6M | ||
| Q1 24 | $80.7M | $7.7M |
总债务ASRTUHT
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTUHT
| Q4 25 | $94.0M | $152.4M | ||
| Q3 25 | $105.8M | $158.6M | ||
| Q2 25 | $93.3M | $165.2M | ||
| Q1 25 | $108.5M | $172.2M | ||
| Q4 24 | $121.1M | $179.5M | ||
| Q3 24 | $130.5M | $181.6M | ||
| Q2 24 | $132.2M | $190.7M | ||
| Q1 24 | $134.5M | $196.5M |
总资产ASRTUHT
| Q4 25 | $267.0M | $564.9M | ||
| Q3 25 | $319.8M | $568.0M | ||
| Q2 25 | $273.8M | $573.0M | ||
| Q1 25 | $286.4M | $573.5M | ||
| Q4 24 | $284.7M | $580.9M | ||
| Q3 24 | $276.0M | $584.3M | ||
| Q2 24 | $279.4M | $586.6M | ||
| Q1 24 | $282.0M | $596.2M |
负债/权益比ASRTUHT
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $49.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTUHT
| Q4 25 | $-30.0M | $49.1M | ||
| Q3 25 | $-4.8M | $10.2M | ||
| Q2 25 | $19.1M | $13.7M | ||
| Q1 25 | $-12.5M | $11.6M | ||
| Q4 24 | $11.5M | $46.9M | ||
| Q3 24 | $-35.0K | $9.9M | ||
| Q2 24 | $7.4M | $12.1M | ||
| Q1 24 | $7.5M | $11.7M |
资本支出强度ASRTUHT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | -0.42× | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
